Back to search
FDAFDA · Food and drugs·Recall number D-1696-2012

Synthroid (levothyroxine sodium) Tablets USP, 112 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-9296-90

Published October 3, 2012 · Recall initiated: July 19, 2012

Summary

FDA records drug Class II recall D-1696-2012, published October 3, 2012 and initiated July 19, 2012. Recalling firm: Abbott Laboratories; Status: Terminated; Reported quantity: 40,464 Bottles; Lot: Lot: 18355A8, Exp. 09/26/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.

What to do

Voluntary: Firm initiated · Letter

Get an email if SYNTHROID has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
SYNTHROID
Manufacturer
Abbott Laboratories
Distributor
Nationwide
UPC
0300747149902
Lot
Lot: 18355A8, Exp. 09/26/13
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Synthroid (levothyroxine sodium) Tablets USP, 112 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-9296-90 recalled?

Yes. FDA published recall D-1696-2012 on October 3, 2012. Reported hazard: Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: SYNTHROID. UPC: 0300747149902.